JP2013070713A - Medical fluid administration device - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a medical fluid administration device capable of being enhanced in its user's convenience.SOLUTION: The medical fluid administration device is a portable medical fluid administration device held on a living body, and includes a medical fluid storage portion 110 for storing a medical fluid, an pressing portion 140 for oppressing a medical fluid bag 110 and a feeding portion 130 for externally feeding the medical fluid stored in the medical fluid bag 110. The medical fluid storage portion 110 is made of a sheet-shaped member, and has a bottom surface part and an upper surface part having a predetermined area, and formed as a bottom surface and an upper surface of the medical fluid storage portion 110 formed by folding the sheet-shaped member, and a side surface part provided between the bottom surface part and the upper surface part to be respectively connected to the respective edges of the bottom and upper surface parts, and formed into a shape folded back odd number of times at least three times in the overlapped direction of the bottom and upper surface parts.

Description

  The present invention relates to a drug solution administration device, and is suitable for application when, for example, insulin is administered into the body.

  In recent years, diabetes has been on the rise in the number of patients worldwide, including Japan. In addition, there is a concern about the associated increase in treatment costs. Among diabetes, type 1 diabetes is a chronic disease that requires treatment to inject an appropriate amount of insulin at an appropriate time. For a long time, manual administration using a syringe or manual administration using an injector has been performed. In order to carry out appropriate treatment more simply, safely, and automatically, an automatic drug solution administration system capable of programming the dose and administration time has been developed.

  This system is composed of an infusion pump, a dedicated infusion set, and a catheter. Currently, a system in which a drug administration device is portable is also used. Recently, in this portable system, in order to eliminate the troublesomeness of the tube of the infusion set and improve the handling, a small and lightweight infusion pump that is attached and fixed to the body surface with double-sided tape without using the infusion set A patch-type drug solution administration device has been introduced in which a catheter is directly inserted from the device (see, for example, Patent Document 1).

  Miniaturization is an important design factor in a patch-type drug administration device that is attached to the body surface. In particular, a drug solution storage unit for storing insulin requires a large volume ratio in the apparatus. The present invention relates to a chemical solution storage unit that improves volumetric efficiency.

Special table 2010-501283

  By the way, in the conventional medicinal-solution administration device, the medicinal solution is delivered from the medicinal solution storage section filled with the medicinal solution into the body using a pump or the like.

  In addition, since the chemical solution cannot be used until the end, it is necessary to mount a larger amount of the chemical solution storage unit than necessary. Also, when using a bag-shaped chemical storage unit that uses a flexible sheet or film of chemicals, in order to use the chemicals to the end, the drains should be placed at the bottom, for example, in a suspended state. It is necessary to devise a solution that can be filled with chemicals until the end, but it is difficult to realize it when considering a portable type that needs to cope with any posture.

  Considering a bag-shaped chemical solution storage unit in which two sheets or films are fused, when the chemical solution is filled, only the central part swells, and the chemical solution cannot be filled in the periphery of the helicopter under the fusion, so Was not good.

  The present invention has been made in consideration of the above points, and an object of the present invention is to propose a drug solution administration device that can improve usability.

  In order to solve this problem, the present invention is a portable chemical solution administration device held in a living body, which stores a chemical solution storage unit that stores a chemical solution, a compression unit that compresses the chemical solution pack, and is stored in the chemical solution pack. And a bottom part that forms a bottom surface and a top surface of the chemical liquid storage part that is formed by folding and having a predetermined area. And a top surface portion and a side surface portion which is connected between the bottom surface portion and the top surface portion and connected to the respective edges, and which has a shape that is folded back at least three times in the direction overlapping the bottom surface portion and the top surface portion.

  As a result, when the chemical solution is delivered from the chemical solution storage unit, the chemical solution can be compressed and delivered by the compression unit, so that it remains in the chemical solution storage unit with the small delivery unit provided in the portable small-sized chemical administration device The amount of the chemical solution can be reduced.

  According to the present invention, when the chemical solution is delivered from the chemical solution storage unit, the chemical solution can be compressed and delivered by the compression unit, so that it is attached to the surface of the living body and used regardless of the body position. The small amount of the drug solution remaining in the drug solution storage unit can be used by the small delivery unit provided in the small drug solution administration device, and it is not necessary to make the drug solution storage unit larger than necessary, and the volumetric efficiency is high. In contrast to the bad bag-like shape, the bellows structure provided on both sides of the bag enables filling of the chemical solution up to the periphery of the helicopter, increasing the volumetric efficiency and realizing a compact chemical solution storage unit. Thus, usability can be improved.

It is a basic diagram which shows the structure of a chemical | medical solution administration system. It is a basic diagram which shows the structure of a chemical | medical solution administration apparatus. It is a disassembled perspective view of a chemical | medical solution storage delivery part. It is a basic diagram which shows before and after storage of a chemical | medical solution. It is a basic diagram which shows the formation process of a chemical | medical solution bag. It is a basic diagram which shows the structure of a filter part. It is a basic diagram which shows the structure of a sending part. It is a disassembled perspective view of a drive control part. It is a basic diagram which shows the mechanism of power transmission. It is a basic diagram which shows the structure of a connector. It is a basic diagram which shows the structure (1) of a puncture flow path part. It is a basic diagram which shows the structure (2) of a puncture flow path part. It is a basic diagram which shows the structure of a crimping and a press part. It is a basic diagram which shows the mode of puncture. It is a basic diagram which shows the structure of an angle adjustment mechanism. It is a basic diagram which shows mounting of the knob part in an angle adjustment mechanism. It is a basic diagram which shows the change of the protrusion angle in an angle adjustment mechanism. It is a basic diagram which shows the circuit structure and functional structure of a chemical | medical solution administration system. It is a basic diagram which shows the structure of a chemical | medical solution filling apparatus. It is a basic diagram which shows the structure of a syringe. It is a basic diagram which shows the structure of a pusher drive mechanism. It is a basic diagram which shows the circuit structure and functional structure of a chemical | medical solution filling apparatus. It is a flowchart which shows a filling process procedure. It is a basic diagram which shows the structure of the sheath part in other embodiment. It is a basic diagram which shows the structure (1) of the puncture flow path part in other embodiment. It is a basic diagram which shows a distance adjustment mechanism. It is a basic diagram which shows the angle adjustment mechanism (1) in other embodiment. It is a basic diagram which shows the structure (2) of the puncture flow path part in other embodiment. It is the schematic which shows the structure of the knob in another embodiment, and a knob support part. It is the schematic which shows the change of the protrusion angle by the angle adjustment mechanism (2) in other embodiment. It is a basic diagram which shows the structure of the puncture release mechanism in other embodiment.

  Hereinafter, an embodiment of the present invention will be described in detail with reference to the drawings.

[1. Configuration of chemical solution administration system]
As shown in FIG. 1, a drug solution administration system 1 wirelessly communicates a signal corresponding to a user's input instruction with a portable drug solution administration device 2 that is held and used by being affixed to the user's skin. The controller 3 for transmitting to the drug solution administration device 2, the charger 4 (FIG. 18) for charging the rechargeable battery 206 (FIG. 8) provided inside the drug solution administration device 2, and the drug solution bag 110 (FIG. 3) includes a chemical solution filling device 5 (FIG. 19) for injecting and filling the chemical solution.

[2. Configuration of chemical administration device]
The chemical liquid administration device 2 stores therein a chemical liquid (for example, insulin), and administers the chemical liquid into the user's body in accordance with a control signal transmitted from the controller 3. As shown in FIG. 2, the drug solution administration device 2 includes a drug solution storage and delivery unit 10, a drive control unit 20, and a puncture channel unit 30 that are detachable from each other.

  In the drug solution administration device 2, after the drug solution storage / delivery unit 10 and the drive control unit 20 are engaged from above and below, the puncture channel unit 30 is slid from the front with respect to the drug solution storage / delivery unit 10 and the drive control unit 20. To be integrated. The medicinal solution administration device 2 is used by being attached to the skin of the user in such a state.

  The size of the drug solution administration device 2 may be reduced to such an extent that it can be affixed to the skin of the user.

[2-1. (Configuration of chemical storage and delivery unit)
As shown in FIG. 3 and FIG. 4, the chemical storage / delivery unit 10 includes a lower casing part 101 that is open on the upper side and has a space inside, and an upper casing that is screwed into the opening of the lower casing part 101. The portion 102 is formed into a flat and substantially rectangular parallelepiped shape.

  The chemical solution storage and delivery unit 10 is provided with a chemical solution bag 110, a filter unit 120, a delivery unit 130, a compression unit 140, and the like in a space formed by the lower casing unit 101 and the upper casing unit 102.

  The lower housing part 101 is provided with a sticking part 103 made of double-sided tape or the like on the bottom face 101A. The medicinal solution administration device 2 is held by the user when the sticking portion 103 is stuck on the user's skin. The bottom surface 101 </ b> A of the lower housing 101 is formed of a transparent material so that the amount of the chemical stored in the chemical bag 110 can be seen from the outside. This makes it possible to check the remaining amount of the chemical solution even after the chemical solution administration device 2 is attached to the user's skin.

  Engagement portions 101B to E made of protrusions extending in the direction in which the drive control unit 20 is arranged are provided on the side surfaces along the longitudinal direction (hereinafter also referred to as the front-rear direction) of the lower housing unit 101. It has been. The engaging portions 101B to 101E are brought into close contact with the chemical solution storage and delivery portion 10 and the drive control portion 20 by engaging with engagement receiving portions 201A to 201D (FIG. 8) described later.

  The lower casing unit 101 is provided with a waterproof packing 101F on a surface in close contact with the upper casing unit 102, and the lower casing unit 101 is screwed to the upper casing unit 102 via the waterproof packing 101F (not shown). Since it is screwed or ultrasonically fused, it is possible to prevent liquid from entering the internal space from between the lower casing portion 101 and the upper casing portion 102.

  A hole 101G into which the leaf spring release rod 144 is inserted is provided on the side surface of the lower housing portion 101 along the front-rear direction. A duckbill-like valve packing (not shown) is inserted into the hole 101G, and the hole is closed when the leaf spring release rod 144 is removed. Further, a bottom 101 </ b> A of the lower housing part 101 is provided with a hole 101 </ b> K into which the injection part 104 is fitted to inject a chemical liquid into the chemical liquid bag 110.

  In addition, an engagement receiving portion 101L that is a recess with which an engagement portion 523A of an injection needle 523 of a chemical liquid filling device 5 to be described later is engaged is provided on the bottom surface 101A of the lower casing portion 101 and around the hole 101K. It is done. The peripheral portion of the hole 104 </ b> K realizes a waterproof function by fitting the injection portion 104, which is an elastic member fused to the chemical solution bag 110, and the lower housing 101.

  Further, the lower casing portion 101 is provided with a concave portion 101H on the front side, which is a space into which a part of the puncture channel portion 30 is fitted when the puncture channel portion 30 is engaged with the drug solution storage and delivery unit 10. . Further, the lower casing portion 101 is provided with projections 101I and 101J protruding in opposite directions to guide the puncture flow path portion 30 so as to be slid and engaged with the medicinal solution storage / delivery portion 10 from the front direction. It is provided along.

  The upper housing part 102 is provided with projecting parts 102A and 102B projecting in the front-rear direction so as to be continuous with the projecting parts 101I and 101J of the lower housing part 101 in the front-rear direction. The upper housing portion 102 is formed such that the central portion 102C sandwiched between the protrusion portions 102A and 102B is one step lower than the other portions in order to form the protrusion portions 102A and 102B.

  The upper housing portion 102 has a concave portion 102D into which a convex portion 301C (FIG. 12) of the puncture flow channel portion 30 is fitted when the puncture flow channel portion 30 is engaged with the drug solution storage and delivery portion 10 at a predetermined position of the central portion 102C. Is provided.

  As shown in FIG. 5, the chemical solution bag 110 as the chemical solution storage unit is formed from a rectangular sheet 111 made of, for example, polyurethane, vinyl chloride, or polyethylene. As shown in FIG. 5 (A), the sheet 111 is a central portion in the longitudinal direction and is a portion (hereinafter also referred to as a central portion) 112 that becomes the bottom surface of the chemical solution bag 110 that is a flexible thermoplastic resin. At least three odd or more (five in the present embodiment) fold lines 113 and 114 are provided at equal intervals on both sides of the sheet. As a result, an even number of portions (hereinafter also referred to as folding portions) 115 and 116 having a predetermined width are formed on the sheet 111 between the adjacent folds 113 and 114, respectively.

  Further, the sheet 111 has portions (hereinafter also referred to as end portions) 117 and 118 that are longer than half of the length in the longitudinal direction in the central portion 112 on the further end side than the folds 113 and 114 from the most ends in the longitudinal direction. Provided.

  In this sheet 111, the folds 113 and 114 are alternately folded into a mountain fold and a valley fold so that the fold portions 115 and 116 overlap the center portion 112, and as shown in FIG. Part of the end side overlaps.

  In the sheet 111, the overlapping portions of the end portions 117 and 118 are fused, and the edges in the width direction are fused. When the edge in the width direction of the sheet 111 is fused, the edge is fused so that the nozzle 105 that connects the space surrounded by the sheet 111 and the external space is sandwiched between the edges.

  Further, at a predetermined position of the central portion 112 of the seat 111, an injection portion 104 provided with a check valve (not shown) formed of, for example, synthetic rubber or the like for injecting the chemical solution into the chemical solution bag 110 from the outside is provided. In this way, a chemical solution bag 110 as shown in FIG. 5C is formed.

  The medical solution bag 110 formed in this way is folded so that the adjacent folding portions 115 and 116 are in contact with each other in a state where the medical solution is not filled, and the central portion 112 and the end portions 117 and 118 are Overlap.

  Therefore, the chemical solution bag 110 is not crushed so that the central portion 112 and the end portions 117 and 118 are in contact with each other without leaving the chemical solution inside when the chemical solution filled therein is sent to the outside through the nozzle 105. Can be sent to the outside.

  By the way, the conventional chemical solution bag is generally formed by fusing the edges of two films, and the chemical solution is injected into the space formed by the two films. As the distance approaches, the distance between the two films becomes shorter.

  Therefore, in the conventional chemical solution administration device using the chemical solution bag, in the space where the chemical solution bag is stored, when the chemical solution is injected near the edge of the chemical solution bag, a useless space is formed in the portion where the chemical solution bag does not expand. Will be. Thus, the conventional drug solution bag has a problem in that the drug solution administration device is enlarged.

  On the other hand, since the chemical solution bag 110 has the folding portions 115 and 116 in the longitudinal direction, the folding portions 115 and 116 separate the center portion 112 and the end portions 117 and 118 when the chemical solution is injected. It spreads in the direction (vertical direction).

  Therefore, the chemical solution bag 110 can expand in the vertical direction even when it is near the edge of the chemical solution bag 110 when the chemical solution is injected by expanding the folding parts 115 and 116. In the space formed with the casing 102, when the chemical solution is injected, a wasteful space is not formed even in a portion near the edge of the chemical solution bag 110, and the chemical solution administration device 2 can be downsized. Yes, thus improving usability.

  As shown in FIG. 6, the filter unit 120 is connected to a side surface of the upper lid 121 having an opening on the lower side and a space in the interior, and a nozzle 105 communicating the inner space and the chemical solution bag 110. A channel pipe 106 communicating with the delivery unit 130 is connected.

  The filter unit 120 is provided with an air vent filter 122 that allows gas to pass but does not allow liquid to pass so as to close the opening of the upper lid 121. The air vent filter 122 is fixed between the upper lid 121 and the lower lid 123 that closes the opening of the upper lid 121 so as to be sandwiched between the O-rings 124 and 125 along the circumferential direction. The upper lid 121 and the lower lid 123 are in close contact with each other by, for example, ultrasonic fusion. The lower lid 123 is provided with a hole 123A penetrating in the vertical direction.

  Thereby, the filter part 120 can discharge | release only gas outside without discharging | emitting a chemical | medical solution from the internal space of the upper cover 121 via the hole 123A provided in the lower cover 123. FIG.

  As shown in FIG. 7, the delivery unit 130 is a so-called piston pump, and a piston 132 is inserted into a cylindrical internal space 131 </ b> A provided in the cylinder unit 131 from one end side.

  The piston 132 is connected to the crankshaft 134 via the crank 133, and slides in the internal space 131 </ b> A of the cylinder portion 131 when the crankshaft 134 rotates. The side surface of the cylinder portion 131 that is in contact with the internal space 131A is the inner wall of the internal space 131A in order to prevent chemicals from leaking outside through the gap between the piston 132 and the inner wall of the internal space 131A of the cylinder portion 131. For example, an X-ring or O-ring packing 135 is provided along the circumferential direction, and is arranged in contact with the piston 132. Further, a gasket made of silicon rubber, butadiene rubber or the like may be attached to the piston 132.

  The crankshaft 134 is provided with a drive magnet 136 as an example of a first power transmission unit provided at one end thereof. A position detection magnet 137 for detecting the position of the piston 132 and the number of strokes is provided on the side surface of the drive magnet 136.

  The drive magnet 136 is a power transmission magnet 209 (FIGS. 8 and 9) as an example of a second power transmission unit with the upper casing unit 102 and the lower casing unit 202 (FIG. 8) interposed therebetween. , And is attracted to and rotated by a power transmission magnet 209 that rotates via a motor 207 and a gear head 208 as will be described later.

  In the delivery unit 130, the crankshaft 134 rotates as the drive magnet 136 rotates, and the piston 132 slides in the internal space 131 </ b> A of the cylinder unit 131 via the crank 133.

  In the cylinder part 131, flow paths 131B and 131C are provided in communication with the internal space 131A on the side opposite to the side where the piston 132 is inserted in the internal space 131A.

  The filter section 120 is connected to the internal space 131A of the cylinder section 131 through the flow path section 106, the check valve 138, and the flow path 131B. The check valve 138 allows the chemical solution to pass from the filter unit 120 to the internal space 131A, but does not allow the chemical solution to pass in the opposite direction.

  In addition, the internal space 131A of the cylinder part 131 is connected to the valve body 108 provided in the upper housing part 102 through the flow path 131C, the check valve 139, and the flow path pipe 107. The check valve 139 allows the chemical solution to pass from the internal space 131A to the valve element 108, but does not allow the chemical solution to pass in the opposite direction.

  The valve body 108 closes the flow path when nothing is inserted, and opens the flow path when the nozzle 302 (FIG. 12) provided in the puncture flow path section 30 is inserted, and The nozzle 302 is communicated.

  Accordingly, the delivery unit 130 rotates the drive magnet 136 and the crankshaft 134 so that the piston 131 slides in the internal space 131A of the cylinder part 131, so that the chemical solution stored in the chemical solution bag 110 is transferred to the puncture delivery unit 30. It is delivered into the user's body through the provided flow path.

  More specifically, the delivery unit 130 pulls out the chemical solution from the chemical solution bag 110 when the piston 132 moves from the top dead center to the bottom dead center, and the internal space when the piston 132 moves from the bottom dead center to the top dead center. The chemical solution drawn out to 131A is delivered to the flow channel tube 107.

  The pressing part 140 includes a presser plate 141, a support part 142, and a leaf spring 143. The press plate 141 is a plate material having an area larger than the central portion 112 of the chemical solution bag 110 and is provided on the upper side of the chemical solution bag 110. The presser plate 141 is supported by a support part 142 fixed to the lower casing part 101 so as to be rotatable in a direction away from and approaching the chemical solution bag 110 around the connecting parts 141A and 142A formed of, for example, a hinge mechanism. The

  The plate spring 143 is a plate material provided in a state of being bent in a substantially V shape between the holding plate 141 and the upper housing portion 102, and the plate portions that are bent in a substantially V shape and are opposed to each other are separated from each other. The force works in the direction to open (the direction to open). Accordingly, when the leaf spring 143 is disposed between the presser plate 141 and the upper housing portion 102, the presser plate 141 is always pressed against the chemical solution bag 110 with a constant force.

  By the way, the compression part 140 is a plate spring release rod between the presser plate 141 and the plate spring 143 from the hole 101G of the lower housing unit 101 before the chemical solution is injected into the chemical solution bag 110 (FIG. 4A). 144 is inserted. At this time, in the pressing portion 140, the presser plate 141 is freely rotatable without the plate spring 143 pressing the presser plate 141.

  Then, when the leaf spring release rod 144 is removed after the chemical solution is injected into the chemical solution bag 110, the compression portion 140 presses the holding plate 114 against the chemical solution bag 110 side. As a result, in the pressing part 140, the presser plate 114 sandwiches the chemical solution bag 110 between the lower casing unit 101 and applies a constant positive pressure to the chemical solution bag 110 (FIG. 4B).

  Thereby, when the dissolved gas exists in the chemical | medical solution bag 110, the compression part 140 can discharge | release dissolved gas through the filter part 120 outside. Note that the check valve 138 connected to the filter unit 120 via the flow channel pipe 106 opens when a pressure difference higher than the positive pressure applied to the drug solution bag 110 by the compression unit 140 is applied as the valve opening pressure. Therefore, the chemical solution does not flow from the chemical solution bag 110 to the delivery unit 130 due to the positive pressure applied by the compression unit 110.

  In addition, when the chemical solution stored in the chemical solution bag 110 is delivered by the delivery unit 130, the compression unit 140 presses the chemical solution bag 110 in a direction to be crushed, so that the chemical solution stored in the chemical solution bag 110 is pushed out without leaving inside. Thus, it can be sent out.

[2-2. Configuration of drive control unit]
As shown in FIG. 8, the drive control unit 20 is formed in a substantially U-shape having a recess 20 </ b> A that matches the shape of the puncture channel unit 30 so that the puncture channel unit 30 is inserted from the front. Is done.

  The drive control unit 20 is a space formed between an upper housing part 201 that is open on the lower side and has a space inside, and a lower housing part 202 that is screwed into the opening of the upper housing part 201. Are provided with a charging antenna 203, a substrate 204, a communication antenna 205, a rechargeable battery 206, a motor 207, a gear head 208, a power transmission magnet 209, magnetic sensors 210 and 211, and the like.

  Engagement receiving portions 201 </ b> A to 201 </ b> D, which are grooves for engaging with the engaging portions 101 </ b> B to E provided in the chemical solution storage / delivery unit 10, are provided on the outer surface along the front-rear direction of the upper casing unit 201.

  In addition, a bolus switch 201E is provided on the upper surface of the upper housing part 201. The bolus switch 201E is pressed by the user when a certain amount of chemical solution is temporarily administered (bolus administration). The bolus switch 201E is provided at a position recessed from the upper surface of the casing unit 201, and can be prevented from being accidentally pressed by the user, for example, by turning over.

  The lower casing 202 is provided with a waterproof packing 202A on the surface that is in close contact with the upper casing 201, and the upper casing 201 is screwed to the lower casing 202 via the waterproof packing 202A (not shown). Since it is screwed or ultrasonically fused, it is possible to prevent liquid from entering the internal space from between the upper casing portion 201 and the lower casing portion 202.

  A charging antenna 203 is affixed to the upper surface of the lower casing unit 202 and receives electricity supplied from a charger 4 (FIG. 18) described later.

  In addition, on the upper surface of the lower casing unit 202, signals are transmitted and received between an electric circuit such as a CPU (Central Processing Unit), a RAM (Random Access Memory), and a ROM (Read Only Memory), and the controller 3 and the chemical filling device 5. A board portion 204 on which a communication antenna 205 is disposed is provided on the upper side of the charging antenna 203.

  In addition, a rechargeable battery 206 is provided on the upper surface of the lower housing portion 202, which is charged by electricity supplied from the charging antenna 203 and supplies electricity to each portion during driving.

  Furthermore, a motor 207, a gear head 208, and a power transmission magnet 209 are provided on the upper surface of the lower casing unit 202 so as to overlap with each other at a position facing the driving magnet 136 of the chemical storage / delivery unit 10.

  Further, on the upper surface of the lower casing portion 202, a position detection magnet 137 disposed on the side surface of the drive magnet 136 is positioned on the circumference where the magnet moves, and along the left-right direction with the power transmission magnet 209 interposed therebetween. Magnetic sensors 210 and 211 are provided respectively.

  The motor 207 rotates the power transmission magnet 209 via the gear head 208. As shown in FIG. 9, the power transmission magnet 209 faces the drive magnet 136 so as to have a polarity that attracts the drive magnet 136 with the chemical storage / delivery unit 10 and the drive control unit 20 in close contact with each other. To be placed.

  When the power transmission magnet 209 is rotated by the motor 207 via the gear head 208, the power transmission magnet 209 rotates with its own rotation while attracting the driving magnet 136 by magnetic force.

  Accordingly, the motor 207 rotates the crankshaft 134 in a non-contact manner via the gear head 208, the power transmission magnet 209, and the driving magnet 136, and slides the piston 132 connected to the crank 133 within the internal space 131A of the cylinder portion 131. Let

  By the way, since the motor 207 slides the piston 132 in a non-contact manner through the magnetic force of the power transmission magnet 209 and the driving magnet 136, it is necessary to detect whether the piston 132 is rotating following the rotation of the motor 207. There is. Therefore, magnetic sensors 210 and 211 for detecting that the piston 132 is sliding are arranged facing the circumference on which the position detection magnet 137 moves.

  More specifically, when the piston 132 is located at the top dead center, the position detection magnet 137 is moved to a position facing the magnetic sensor 210, so that the magnetic sensor 210 generates the magnetic force of the position detection magnet 137. By detecting this, it is detected that the piston 132 is located at the top dead center.

  Further, when the piston 132 is located at the bottom dead center, the position detection magnet 137 is moved to a position facing the magnetic sensor 211, so that the magnetic sensor 211 detects the magnetic force of the position detection magnet 137, thereby It is detected that 132 is located at the bottom dead center.

  Thus, the magnetic sensors 210 and 211 can detect the sliding of the piston 132 or the number of strokes by detecting that the piston 132 is alternately moving to the top dead center and the bottom dead center. .

  Therefore, as will be described in detail later, the microcomputer 220 (FIG. 18) includes different magnetic sensors 210 and 211 provided in the same space formed by the upper housing portion 201 and the lower housing portion 202. It is possible to check the drive of the sending unit 130 provided in the space formed by the lower casing unit 101 and the upper casing unit 102 without contact.

  Electricity is supplied from the rechargeable battery 206 to the puncture channel unit 30 on the front surface of the recess 20A that comes into contact with the upper casing unit 201 when the puncture channel unit 30 is in close contact therewith. A connector unit 212 for transmitting and receiving various signals is provided. As shown in FIGS. 10A and 10B, the connector part 212 has a structure in which a waterproof rubber 212B covers the outside of the electric connector part 212A in which a plurality of spring connectors 212C for transmitting and receiving electricity and various signals are collected. It becomes.

  Similarly, the connector part 350 (FIG. 12) of the puncture flow path part 30 connected to the connector part 212 also has a waterproof rubber on the outside of the electric connector part 350A in which a plurality of connector parts 350C for transmitting and receiving electricity and various signals are collected. The structure is covered with 350B.

  Thereby, in the drive control part 20, when the connector part 212 is connected with the connector part 350, it can prevent that the liquid touches the electrical connector parts 212A and 350B by the waterproof rubbers 212B and 350B. In addition, when inserting the puncture flow path section 30 into the drug solution storage / delivery section 10 using one pin of the connector, the length is not contacted at the limit where insertion is permitted (when sufficient insertion is not performed). This pin is provided and connected to the ground potential on the puncture flow path section 30 side, and whether the potential of this pin is the ground potential or not is checked on the drive control section 20 side. In this case, the insertion of the puncture channel 30 is monitored by displaying an alarm indicating that the puncture channel 30 is insufficiently inserted.

[2-3. (Configuration of puncture channel)
As shown in FIG. 11 and FIG. 12, the puncture flow path part 30 is fitted in the space of the recesses 101H and the recesses 20A formed in a state where the drug solution storage and delivery part 10 and the drive control part 20 are engaged. It has an elongated shape. The puncture flow path part 30 is provided with each part in the internal space of the housing part 301 that forms the outer shell. Note that FIG. 11A illustrates an external configuration, and FIG. 11B illustrates an internal configuration. In FIG. 12, a part is shown in a cross section for convenience of explanation.

  When the puncture flow path unit 30 is fitted to the drug solution storage and delivery unit 10, the housing unit 301 includes a bottom surface 301 </ b> A located on the same plane as the bottom surface 101 </ b> A of the lower housing unit 101 and the center of the upper housing unit 102. A bottom surface 301B located at a height facing and adjacent to the portion 102C.

  The housing portion 301 is provided at a position where a convex portion 301C that fits into the concave portion 102D of the upper housing portion 102 when the puncture flow path portion 30 is fitted to the drug solution storage and delivery portion 10 faces the concave portion 102D in the bottom surface 301B. .

  Further, the casing 301 includes a protrusion 101I of the lower casing 101 and a protrusion 102A of the upper casing 102, a protrusion 101J of the lower casing 101, and a protrusion of the upper casing 102. Guide grooves 301D and 301E that respectively engage with the portion 102B are formed on the side surfaces along the front-rear direction.

  The casing 301 is provided with a recess 301G on the upper surface 301F for hooking a user's finger when removing the puncture flow path unit 30 from the drug solution storage / delivery unit 10 and the drive control unit 20 that are fitted.

  The casing 301 is curved from the upper surface 301F to the front surface 301G, and an angle adjustment mechanism 340, which will be described in detail later, is provided on the curved surface 301H.

  In addition, the casing 301 is provided with a hole 301I at a position facing the valve body 108 of the chemical liquid storage / delivery section 10 in a state where the puncture flow path section 30 is fitted to the chemical liquid storage / delivery section 10. The nozzle 302 to be inserted is fixed so as to penetrate the hole 301I. The nozzle 302 is fixed without providing a gap with the hole 301I.

  One end of the nozzle 302 is inserted into the valve body 108 and communicated with the flow channel tube 107 in a state where the puncture flow channel unit 30 is fitted to the drug solution storage and delivery unit 10. The nozzle 302 is connected to a running water sensor 303 at the other end.

  The flowing water sensor 303 detects whether or not the passing chemical solution is flowing. For example, the thermistor is heated at a constant current to detect the temperature change of the thermistor due to the continuous flow of the chemical solution, or the thermistor alone is used as a heating source. In addition to the method used for the temperature sensor, the heating source and the temperature sensor are used separately. The heating source is a resistor, heater wire, semiconductor, and the temperature sensor is a thermo file, platinum resistor, semiconductor, etc. Things are adaptable.

  The flowing water sensor 303 has a puncture channel needle 304 connected to an end opposite to the end to which the nozzle 302 is connected, and allows the nozzle 302 and the puncture channel needle 304 to communicate with each other. The puncture flow path needle 304 is bent so that one end side connected to the running water sensor 303 is folded back on the S-shape, is arranged along the front-rear direction therefrom, and reaches the bottom surface 301A on the other end side. The puncture channel needle 304 is made of a metal member, but is a 28 gauge hollow tube, for example, which can be easily bent.

  The puncture channel needle 304 is fixed by a fixing portion 305 that protrudes inward from the housing portion 301 at a position immediately after being folded back on the S-shape.

  Puncture channel needle 304 has a part (hereinafter also referred to as an elastic portion) 304A on the front side from a position where it is fixed to fixing portion 305 spirally wound. The elastic portion 304A is extendable in the front-rear direction.

  The puncture channel needle 304 has a sharply sharp shape at a tip portion (hereinafter also referred to as a tip portion) 304B that is bent so as to reach the bottom surface 301A.

  The puncture flow path needle 304 having such a shape sends out the drug solution flowing from the flowing water sensor 303 to the outside through the inner space from the distal end portion 304B.

  The puncture channel needle 304 is covered by, for example, the sheath portion 310 from the distal end portion 304B to the elastic portion 304A.

  The sheath part 310 is made of, for example, Teflon (registered trademark) or polyethylene, and the sheath 311 has flexibility, and is soft, for example, made of Teflon (registered trademark), polyolefin, or polyurethane. It is comprised by the expansion | extension part 312 which has the characteristic (permanent deformation, plastic deformation) which does not return to a shape. Examples of the material that is soft and easily deformed and has the property of not returning to the extension 312 include a material that is crosslinked by ultraviolet rays at a high temperature, such as a heat-shrinkable tube, such as polyolefin, Teflon (registered trademark), silicon. Polyvinyl chloride, polyvinyl fluoride fluoride, etc. can be used.

  The sheath 311 covers most of the puncture channel needle 304 from the distal end 304B to the front of the elastic portion 304A, and is not fixed to the puncture channel needle 304.

  The extending portion 312 covers the puncture channel needle 304 from a position overlapping one end side of the elastic portion 304A side of the sheath 311 to just before the elastic portion 304A, and one end on the fixed portion 305 side is the puncture channel needle. The other end is fixed to the sheath 311. The extending portion 312 is fixed so as to seal the gap between the puncture flow path needle 304 and the sheath 311 along the circumferential direction so that the liquid does not leak from the gap at both fixed ends.

  A caulking 306 that fixes the puncture channel needle 304 and the sheath 311 together is provided at a predetermined position on the distal end portion 304B side of the elastic portion 304A of the puncture channel needle 304. The caulking 306 is made of a material that deforms when a certain force is applied, such as aluminum or copper.

  The caulking 306 is crushed from the left and right direction after the puncture flow path needle 304 and the sheath 311 are inserted into the ring hole from the state of the ring shape, and a part of the vertical direction overlaps, and the puncture flow path needle 304 and the sheath 311 are overlapped. Tighten and fix. Thereby, the sheath 311 is fixed so as not to slip with respect to the puncture flow path needle 304. The caulking 306 is bonded to the sheath 311 and does not leave the sheath 311 even when the caulking 306 is loosened.

  The puncture flow path part 30 is provided in front of the caulking 306 and a movement restricting part 307 at a position away from the caulking 306 by a predetermined distance. As will be described later in detail, the predetermined distance is a distance at which the puncture flow path needle 304 and the sheath 311 protrude from the bottom surface 301A of the housing 301, that is, a depth at which the puncture flow path needle 304 and the sheath 311 are punctured to the user. It is the same distance as the distance, and is set to 10 mm in the present embodiment. The movement restricting portion 307 is fixed to the housing portion 301 and is arranged so that the puncture flow path needle 304 and the sheath portion 310 can be inserted into a hole provided in the center without contacting.

  The puncture flow path section 30 is provided with a puncture mechanism 320 at a position behind the caulking 306 and ahead of the extension section 312. The puncture mechanism 320 includes a fixed plate 321, a spring 322, a support plate 323, and a pressing portion 324.

  The fixing plate 321 is fixed to the housing part 301 and is arranged so that the puncture flow path needle 304 and the sheath part 310 can be inserted into a hole provided in the center without contact.

  A spring 322 is disposed in front of the fixed plate 32 1. The spring 322 is arranged so as to pass through the inner space without contact between the puncture flow path needle 304 and the sheath portion 310, and is arranged in a state where it is sandwiched between the fixed plate 321 and the support plate 323 and compressed more than the natural length. Is done.

  The support plate 323 is arranged so that the puncture flow path needle 304 and the sheath portion 310 are inserted without contacting each other, and is a surface on the opposite side to the surface where the spring 322 is in contact with the puncture flow path needle 304 and the sheath portion. The push portion 324 is supported below 310. The support plate 323 is held so as not to move forward by the puncture release mechanism 330 at a position lower than a position where the pressing portion 324 is supported on the same surface as the surface supporting the pressing portion 324.

  As shown in FIG. 13, the pressing portion 324 has a substantially cylindrical shape, and has a negative shape (one character type) whose tip is long in the vertical direction and short in the horizontal direction. The pressing portion 324 is supported by the support plate 323 so that the tip is located between members overlapping on the lower side of the portion of the caulking 306 extending in the vertical direction.

  The puncture release mechanism 330 includes a limiting portion 331, a spring 332, and an actuator 333.

  The restricting portion 331 has a portion extending in the front-rear direction and a portion extending in the up-down direction so that the cross section has a substantially L shape, and is provided near the center of the portion extending in the front-rear direction. The rotary shaft 331A is held rotatably. The restricting portion 331 is disposed so as to support the support plate 323 with the surface on the rotating shaft 331A side of the portion extending in the vertical direction, and restricts the support plate 323 from moving in the forward direction.

  In the restricting portion 331, a spring 332 is connected to the lower surface on the front side of the rotating shaft 331A of the portion extending in the front-rear direction, and the protruding portion 333A of the actuator 333 is in contact with the upper surface on the rear side of the rotating shaft 331A.

  One end of the spring 332 is connected to the restricting portion 331 and the other end is connected to the bottom surface 301B side of the housing portion 301. The spring 332 is arranged in a state in which a force is always applied in a direction in which the spring 332 is to be contracted.

  The actuator 333 is configured to move the protrusion 333A in the front-rear direction when electric power is supplied, and is disposed in a state where the protrusion 333A is in contact with the limiting portion 331.

  The spring 322 is sandwiched between the fixed plate 321 and the support plate 323 and compressed more than the natural length, the limiting portion 331 is in contact with the support plate 323, and the projection 333A of the actuator 333 is disposed in contact with the limiting portion 331. The state is also referred to as an initial state (FIGS. 12 and 14A). In FIG. 14, for convenience of explanation, the puncture channel needle 304 and the sheath 311 are illustrated in a straight state in which they are not bent, but in reality, a part thereof is bent as described above.

  In the initial state, when the actuator 333 is driven and the protrusion 333A is moved backward to release the restricting part 331 from the protrusion 333A, the restricting part 331 is rotated by the force of returning to the natural length of the spring 332 It is rotated counterclockwise around the shaft 331 </ b> A and moves away from the support plate 323.

  In the puncture mechanism 320, when the restricting portion 331 is separated from the support plate 323, the contracted spring 322 extends to return to the natural length and pushes the support plate 323 and the pressing portion 324 in the forward direction. The pushing portion 324 pushed in the forward direction pushes the caulking 306 forward together with the puncture channel needle 304 and the sheath 311 until the caulking 306 comes into contact with the movement restricting portion 307.

  At this time, the caulking 306 moves in the forward direction along the caulking guide 308 where the overlapping portion on the upper side of the portions extending in the vertical direction sandwiches the puncture channel needle 304 and the sheath 311.

  By the way, the cross section of the caulking guide 308 has a U-shape with an opening at the bottom, and the caulking 306 fits from the direction in which the caulking guide 308 is opened in the overlapping portion on the upper side. Is retained.

  When the caulking 306 moves in the forward direction, the elastic portion 304A of the puncture channel needle 304 is extended (FIG. 14B). The puncture flow path needle 304 and the sheath 311 protrude from the bottom surface 301A of the housing 301, and the distal end 304B punctures the user and enters the user's body together with the sheath 311.

  In the puncture mechanism 320, the spring 322 continues to extend even after the caulking 306 contacts the movement restricting portion 307, and the tip of the pressing portion 324 enters between members overlapping below the caulking 306. At this time, the pusher 324 opens the overlapping members below the caulking 306 on both sides, and loosens the tightening of the caulking 306 with respect to the puncture channel needle 304 and the sheath 311.

  When the tightening by the caulking 306 is loosened, the fixation by the caulking 306 to the puncture channel needle 304 is released. Then, in the puncture channel needle 304, the elastic portion 304A contracts to the natural length, and the distal end portion 304B returns to the initial position inside the bottom surface 301A.

  At this time, in the sheath part 310, the sheath 311 is fixed to the caulking 306 and cannot move. Therefore, as the elastic part 304A contracts, the extension part 312 whose one end is fixed to the puncture channel needle 304 extends.

  The sheath portion 310 is maintained in a state in which the distal end portion of the sheath 311 protrudes from the bottom surface 301A because the extension portion 312 that extends at one end does not return to the original shape (FIG. 14C).

  In this way, when puncturing the user, the puncture channel section 30 punctures with the metal puncture channel needle 304 having a sharp tip 304B, and then inserts only the flexible sheath 311 into the body. Subsequently, the puncture channel needle 304 made of metal can be returned to the outside of the body.

  Therefore, the medicinal solution administration device 2 does not leave the metal puncture channel needle 304 in the body while the user is using it, and can continue to insert only the flexible sheath 311 into the body. It is possible to reduce pain and discomfort to the user, thus improving usability.

  On the other hand, in the conventional drug solution administration device, one end of the sheath is connected to the needle through a packing, and after the needle and the sheath are punctured into the skin, the sheath is inserted into the packing portion when the needle is pulled out of the body. It was made to slide and stay in that position.

  Therefore, in the conventional liquid medicine administration device, the gap between the needle and the sheath is sealed with the packing, so that the liquid medicine leaks, or when the seal is strengthened, the friction between the needle and the packing increases and the needle reaches a sufficient depth. There was a possibility not to sting.

  On the other hand, since the medicinal solution administration device 2 is fixed without providing a gap with the puncture channel needle 304 at one end of the elongated portion 312, the medicinal solution does not leak. In addition, there is no hindrance to the puncturing operation due to the friction between the packing and the needle.

  By the way, the puncture flow path section 30 (FIGS. 11 and 12) is forward of the movement restricting section 307 and on the curved section 301H of the main body 301, the angle at which the puncture flow path needle 304 and the sheath 311 project with respect to the bottom surface 301A (hereinafter referred to as “the puncture flow path section 30” , Which is also called a protrusion angle) is provided. Since the bottom surface 301A is in contact with the user's skin, the protruding angle is the same as the angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's skin (hereinafter also referred to as the puncture angle).

  As shown in FIG. 15, the angle adjustment mechanism 340 is supported by a support portion 341 formed of an L-shaped column whose one end is fixed to the housing portion 301. The support portion 341 is a concentric circular shape at the end surface arranged to be orthogonal to the left-right direction on the side opposite to the one end fixed to the housing portion 301, and a plurality of (four in this embodiment) concave portions at a predetermined angle. 341A is provided. The concave portion 341A is provided at a position where the puncture angle of the puncture channel needle 304 and the sheath 311 is 20 ° to 90 °, as will be described in detail later.

  The angle adjusting mechanism 340 is provided with a central portion 342 that is concentric with the concave portion 341A and has a convex portion 342A projecting so as to fit into the concave portion 341A at a position facing the end surface of the support portion 341. The central portion 342 is supported by the support portion 341 at a position where the protruding convex portion 342A fits into the concave portion 341A while being pressed toward the support portion 341 by the screw 345 through the spring 343 and the spring pressing plate 344.

  The center portion 342 is provided with a shaft portion 346 in a direction orthogonal to the rotation axis when the center portion 342 rotates. The shaft portion 346 has a cylindrical shape, one end is connected to the holding portion 347 that holds the puncture channel needle 304 and the sheath 311, and the other end is connected to the knob portion 348 that is held when the angle is adjusted by the user. Is done.

  The holding portion 347 is a tube having an inner diameter that is thicker than the outer shape of the sheath 311, and the puncture flow path needle 304 and the sheath 311 are inserted therethrough, and the puncture flow path needle 304 and the sheath 311 are held without being fixed.

  As shown in FIG. 16, the knob portion 348 includes a knob 348A held by the user and a knob support portion 348B that supports the knob 348A. The knob portion 348 is placed so that both ends of the knob support portion 348B are hooked on rail portions 301K and 301M whose left and right sides of the opening 301J provided in the curved portion 301H of the housing portion 301 are L-shaped in cross section. The

  The knob support portion 348B is placed so as to be sandwiched between the housing portion 301 and the panel portion 349 provided on the curved surface 301H of the housing portion 301. The panel portion 349 opens so that the knob 348A can move in a direction along the curved surface 301H (hereinafter also referred to as a curved direction), and has a shape that is longer in the curved direction than the rail portions 301K and 301M. doing.

  A waterproof packing 348C is provided on the edge of the upper surface of the knob support portion 348B, and prevents liquid from entering the housing portion 301 from between the knob support portion 348B and the panel portion 349.

  In the angle adjusting mechanism 340 having such a configuration, the holding portion 347 is rotated according to the rotation of the shaft portion 346 around the center portion 342 when the knob portion 348 is moved in the bending direction by the user. .

  Thereby, as shown in FIGS. 17 (A) and 17 (B), the angle adjusting mechanism 340 sets the protrusion angle of the puncture flow path needle 304 held by the holding portion 347 and the bottom surface 301A of the sheath 311 to 20 ° to 90 °. Change in range. Note that FIG. 17A shows a case where the projection angle is 90 °, and FIG. 17B shows a case where the projection angle is 20 °.

  That is, the angle adjustment mechanism 340 can change the puncture angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's epidermis arranged in parallel with the bottom surface 301A in the range of 20 ° to 90 °. The puncture channel core 304 and the sheath 311 are set so that the tip 304B does not come out of the housing 301A at a puncture angle at which the distance between the tip 304B and the housing 301A varies depending on the puncture angle.

  Note that the distal end portion 304B of the puncture channel needle 304 and the distal end of the sheath 311 are arranged so as to close the opening 301N provided in the bottom surface 301A and come into contact with the outer periphery of the sheath 311. Held by the unit 309.

  The tip holding portion 309 is fitted to an L-shaped rib provided inside the bottom surface 301A, and both sides are shifted in the front-rear direction along the inside of the front surface 301G and the back surface 301V of the 301. Due to the flexibility, even if the distal end portion 304B of the puncture flow path needle 304 and the distal end of the sheath 311 are moved to the angle adjusting mechanism 340, they can follow it and continue to block the opening 301N. Accordingly, liquid can be prevented from entering the housing portion 301.

  The tip holding portion 309 includes an air vent filter 309A that covers the tip portion 304B of the puncture channel needle 304 and the tip of the sheath 311 at a position further ahead of the tip portion 304B of the puncture channel needle 304. Provided.

  Therefore, the air vent filter 309A can discharge only the air present in the puncture channel needle 304 to the outside without leaking the drug solution flowing through the puncture channel needle 304 before use by the user. .

  Thus, in the drug solution administration device 2, the angle adjustment mechanism 340 can change the protrusion angle of the puncture flow path needle 304 and the bottom surface 301A of the sheath 311 with respect to the bottom surface 301A within a range of 20 ° to 90 ° in accordance with the operation of the user.

  By the way, the human body has skins such as epidermis and dermis up to about 1.5 mm to 4 mm from the body surface, and there is subcutaneous tissue at a depth of about 4 mm to 9 mm from the body surface inside, and further inside Have muscles.

  For example, when insulin is administered from the outside, it is generally administered to a subcutaneous tissue at a depth of about 4 mm to 9 mm from the surface in consideration of the burden on the user, pain, absorption rate of insulin, and the like.

  However, although the depth of the subcutaneous tissue varies depending on individual differences such as its position and age, physique, gender, etc., since conventional drug solution administration devices puncture a fixed distance at a fixed puncture angle, for some users Insulin could not be administered to the subcutaneous tissue.

  On the other hand, the medicinal-solution administration device 2 can change the puncture angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's epidermis in the range of 20 ° to 90 ° by the angle adjustment mechanism 340, so By adjusting, it is possible to puncture to an arbitrary depth, and it is possible to reliably puncture the subcutaneous tissue that is optimal for all users. In recent years, by administering a drug solution to the dermis layer, it is possible to obtain the same medicinal effect with a small amount of drug solution compared to when administered subcutaneously, and therefore it is possible to set the puncture distance to the dermis. Thus, the medicinal solution administration device 2 can improve usability.

  By the way, when the drive control unit 20 is in close contact with the housing unit 301, the connector unit 350 is bonded to the hole 301P provided at a position facing the connector unit 212 of the drive control unit 20 without any gap. As shown in FIGS. 10A and 10B, the connector part 350 covers the outside of the electric connector part 350A in which a plurality of connector parts 350C for transmitting and receiving electricity and various signals are collected with a waterproof rubber 350B. Constructed.

  Thus, the medicinal solution administration device 2 includes the puncture channel unit 30 provided with the puncture channel needle 304 for puncturing the user's skin, the medicinal solution storage and delivery unit 10 provided with the medicinal solution bag 110 for storing the medicinal solution, and the delivery. It is provided separately from the drive control unit 20 provided with the motor 208 for operating the unit 130 and the substrate unit 204.

  Therefore, in the drug solution administration device 2, for example, even when the puncture fails, only the puncture flow path portion 30 needs to be replaced, which is convenient.

  On the other hand, in the conventional liquid medicine administration device, since the needle for puncturing the user's skin, the liquid medicine bag for storing the liquid medicine, the motor, etc. are all provided in the same housing, for example, when puncture fails Had to replace the entire device, which was not only convenient, but also increased the economic burden.

[3. (Circuit configuration of chemical solution administration system etc.)
Next, the circuit configuration and functional configuration of the drug solution administration system 1 will be described with reference to FIG.

  The controller 3 includes a microcomputer 301, a battery 302, a battery monitoring unit 303, a mode switch 304, a numerical value setting switch 305, a display unit 306, a transmission unit 307, a reception unit 308, and a communication antenna 309.

  The microcomputer 301 is a computer including a CPU, a RAM, a ROM, and the like. The CPU reads the basic program stored in the ROM into the RAM and executes it as a whole, and at the same time, the CPU is stored in the ROM. Various processes are executed by reading various programs into the RAM and executing them.

  The battery 302 supplies power to each unit. The battery monitoring unit 303 monitors the presence / absence or remaining amount of the battery 302 and notifies the CPU 301 of it.

  The mode switch 304 is a switch for setting a basal mode in which a chemical solution is continuously administered for a long time and a bolus mode in which a chemical solution is temporarily administered. The numerical value setting switch 305 is a switch for setting the dose per hour and the administration time of the drug solution.

  The microcomputer 301 displays on the display unit 306 contents corresponding to the operation on the mode switch 304 and the numerical value setting switch 305, and transmits a signal indicating the contents to the drug solution administration device 2 via the transmission unit 307 and the communication antenna 309. To do.

  In addition, when the microcomputer 301 receives the signals transmitted from the drug solution administration device 2 and the drug solution filling device 5 by the communication antenna 309, the microcomputer 301 acquires the signals via the reception unit 308 and displays the contents corresponding to the signals on the display unit 306. As a result, the user is notified and processing corresponding to the content is executed.

  On the other hand, in the drug solution administration device 2, the electric circuit is operated by the power supply supplied from the rechargeable battery 206, and the microcomputer 220 provided in the drive control unit 20 performs overall control.

  The microcomputer 220 is a computer including a CPU, a RAM, a ROM, and the like. The CPU reads and executes a basic program stored in the ROM and executes the overall control, and the CPU is stored in the ROM. Various processes are executed by reading various programs into the RAM and executing them.

  When the microcomputer 220 receives the signal transmitted from the controller 3 received by the communication antenna 205 via the receiving unit 222, the microcomputer 220 operates each unit according to the content of the signal.

  Specifically, the puncture angle is adjusted by operating the puncture angle adjusting mechanism 340, and the microcomputer 220 administers the chemical solution in a state where the chemical solution administration device 2 is attached to the user via the attaching unit 103. When a signal to be transmitted is supplied from the controller 3, it is confirmed by connection of the connector parts 212 and 350 whether or not the puncture flow path part 30 is connected to the drive control part 20. The microcomputer 220 drives the puncture release mechanism 330 to puncture the user with the puncture channel needle 304 and the sheath 311.

  When the microcomputer 220 receives a signal indicating the chemical dose and the administration rate from the controller 3, the microcomputer 220 rotates the motor 207 to drive the delivery unit 130 to administer the chemical at the chemical dose and the administration speed. Then, the drug solution is administered into the user's body.

  At this time, in the drug solution administration device 2, the drug solution stored in advance in the drug solution bag 110 via the injection part 129 is used via the air vent filter 104, the delivery part 130, the running water sensor 303, the puncture channel needle 304, the sheath 311, and the like. It is administered to the body of a person.

  While the drug solution is being administered, the microcomputer 220 monitors the rotation speed of the motor 207 via the encoder 223 and detects whether the drug solution is flowing via the flow detection control unit 224. The flow detection control unit 224 heats the thermistor of the flowing water sensor 303 and monitors the temperature change of the thermistor.

  The microcomputer 220 detects whether the piston 132 is sliding based on the magnetic force detected by the magnetic sensors 210 and 211.

  If the motor 207 is not rotating normally, the piston 132 is not sliding normally, or the chemical is not flowing, the microcomputer 220 performs again, and the state does not change. Each unit is stopped, and a message to that effect is transmitted to the controller 3 via the transmission unit 221 and the communication antenna 205.

  When charging the rechargeable battery 206, the microcomputer 220 controls the receiving / charging circuit 224 to receive the electricity supplied from the charger 4 via the charging antenna 203 to charge the rechargeable battery 206. The rechargeable battery 206 is provided with a battery safety circuit unit 225, and the battery safety circuit unit 225 prevents overcharge, overdischarge and overcurrent during charging.

  The charger 4 includes an outlet 401, an AC / DC converter 402, a high frequency converter 403, and a transmission antenna 404. The charger 4 converts alternating current sent from the outlet 401 into direct current by the AC / DC converter 402, converts it to high frequency by the high frequency conversion unit 403 for transmission by the transmission antenna 404, and then passes through the transmission antenna 404. Then, electricity is transmitted to the drug solution administration device 2.

  Therefore, in the drug solution administration device 2, the drug solution storage and delivery unit 10 including the drug solution bag 110 and the puncture channel unit 30 including the puncture channel needle 304 and the sheath 311 are used only once from the hygiene viewpoint that the drug solution is used. On the other hand, the drive control unit 20 that does not use the chemical solution can be used many times by attaching and detaching the chemical solution storage and delivery unit 10 and the puncture flow path unit 30. At this time, since the rechargeable battery 206 of the drive control unit 20 is charged by the charger, it can be used multiple times.

[4. (Configuration of chemical filling device)
Next, the chemical solution filling device 5 that fills the chemical solution bag 110 of the chemical solution administration device 2 with the chemical solution will be described.

[4-1. (Appearance structure of chemical filling device)
As illustrated in FIG. 19, the chemical filling device 5 includes a start / stop switch 502, a mode setting switch 503, and a numerical value input switch 504 that accept an input operation by a user, on the upper side of the front surface 501 </ b> A of a main body 501 that is a substantially rectangular parallelepiped. A display unit 505 for displaying input contents, operation contents, and the like is provided.

  Further, the main body part 501 is provided with a chemical liquid administration device holding part 506 for holding the chemical liquid administration device 2 on the front surface 501A. The drug solution administration device holding unit 506 holds the drug solution administration device 2 so that the bottom surface 101A of the drug solution administration device 2 is on the near side.

  The main body 501 is provided with syringe holding parts 507 and 508 on the front surface 501A for holding the syringe 510.

  As shown in FIG. 20, the syringe 510 includes a cylindrical hollow outer tube 511 and a pusher 512 that is slidably inserted into the outer tube 511.

  The outer cylinder 511 includes a cylinder part 511A, a tip connection part 511B, a flange 511C, side connection parts 511D and 511E, and an end surface of the cylinder part 511A is opened, and a pusher 512 is inserted through the opening.

  The outer cylinder 511 is formed with a tip connection part 511B that protrudes thinly at the tip of the cylinder part 511A, and a flange 511C is formed on the outer periphery of the end of the outer cylinder 511. As for the outer cylinder 511, the injection | pouring tube 520 is connected to the front-end | tip connection part 511B, and the interior space of the cylinder part 511A and the injection | pouring tube 520 are connected.

  As will be described in detail later, the outer cylinder 511 is formed with side connection parts 511D and 511E in which holes for communicating the internal space and the external space of the outer cylinder 511 are formed on the side surface of the cylinder part 511A. The outer cylinder 511 is made of, for example, rubber, and a flexible suction tube 521 and a pump tube 522 are connected to the side connection parts 511D and 511E, respectively, and the internal space of the cylinder part 511A communicates with the suction tube 521 and the pump tube 522. The

  The pusher 512 includes a gasket 512A, a rod 512B, and a flange 512C. The rod 512B has a gasket 512A connected to one end and a flange 512C connected to the other end. The gasket 512A is in close contact with the inner wall of the outer cylinder 511 without any gap.

  The syringe holding part 507 protrudes from the front surface 501A of the main body part 501 so that the flange 511C of the outer cylinder 511 is hooked. The syringe holder 507 has a structure in which the flange is sandwiched from the up and down direction without a backlash by a concave groove into which the resin flange 511C is press-fitted so that the outer cylinder 511 does not move in the up and down direction.

  The syringe holding part 508 protrudes from the front surface 501A of the main body part 501 so as to cover the vicinity of the tip connection part 511B, which is the cylinder part 511A of the outer cylinder 511.

  Accordingly, the syringe holding portions 507 and 508 can hold the outer cylinder 511 vertically so that the distal end connecting portion 511B faces downward.

  The main body 501 is provided with a pusher drive mechanism 530 that moves the pusher 512 in the vertical direction on the front surface 501A. As shown in FIG. 21, the pusher driving mechanism 530 includes a motor 531, a gear head 532, a feed screw 533, and a pusher holding portion 534. The motor 531, the gear head 532, and the feed screw 533 are provided inside the main body portion 501, and a part of the pusher holding portion 534 is provided so as to protrude from the front surface 501 </ b> A.

  The motor 531 rotates the feed screw 533 via the gear head 532 and moves the pusher holding portion 534 screwed to the feed screw 533 in the vertical direction. The pusher holding portion 534 is screwed into the feed screw 533 inside the main body portion 501 by a clutch mechanism, and holds the flange 512C of the pusher 512 from above and below at a portion protruding from the front surface 501A of the main body portion 501.

  At this time, the pusher holding portion 534 holds the pusher 512 so that the gasket 512A of the pusher 512 is positioned above the side connection portions 511D and 511E provided in the tube portion 511A of the outer tube 511.

  Therefore, in the pusher drive mechanism 530, the pusher 512 is moved in the vertical direction above the side surface connection portions 511D and 511E in the main body portion 501 by rotating the motor 531.

  A flexible injection tube 520 made of, for example, polypropylene, polyolefin, polyvinyl chloride, silicon, or the like is connected to the distal end connection portion 511B of the main body portion 501. The injection tube 520 has an injection needle 523 connected to the end opposite to the end to which the tip connection portion 511B is connected, and closes the inner space of the injection tube 520 to the end side to which the tip connection portion 511B is connected. A clamp 540 is provided to be freely opened and closed.

  The injection needle 523 is provided with an engaging portion 523A that is engaged with an engaging receiving portion 101L provided on the bottom surface 101A of the drug solution administration device 2, and the engaging portion 523A is engaged with the engaging receiving portion 101L. At this time, the length of the needle 523B is set to a length that does not reach the drug solution bag 110.

  The suction tube 521 to which the side connection part 511D is connected to one end has the suction needle part 524 connected to the opposite end, and closes the inner space of the suction tube 521 to the end side to which the side connection part 511D is connected. A clamp 541 is provided to be freely opened and closed.

  The suction needle portion 524 is provided with two needles 524A and 524B. A suction tube 521 is communicated with the needle 524A, and the needle 524B is shorter than the needle 524A and has a length that does not contact the drug solution in the vial 570. Nothing is connected and both ends are open and used as a ventilation needle.

  The pump tube 522 to which the side connection part 511E is connected at one end is connected to the pump 525 provided inside the main body 501 at the opposite end, and the pump tube 522 is connected to the side to which the side connection part 511E is connected. A clamp 542 for closing the inner space is provided to be openable and closable.

  The clamps 540, 541, and 542 are opened and closed by an actuator (not shown).

  By the way, ultrasonic sensors 550 and 551 for measuring the amount of the chemical liquid put in the outer cylinder 511 transmit on the surface facing the outer cylinder 511 of the syringe holder 508, and the receiving elements are paired. They are separated by a predetermined interval. This interval is set so that the space between the surfaces parallel to the ultrasonic sensors 550 and 551 in the outer cylinder 511 is the same as the amount of the drug solution injected into the drug solution bag 110 of the drug solution administration device 2.

  The ultrasonic sensor 550 provided in the cylindrical portion 511A of the outer cylinder 511 of the syringe 510 and the ultrasonic sensor 551 provided in the distal end portion 511B of the outer cylinder 511 of the syringe 510 are configured so that the transmitting element transmits ultrasonic waves toward the receiving element. It is fired and the case where the outer cylinder is filled with the chemical solution and the case where it is not filled are determined by the output of the receiving element.

  Specifically, the fact that the prescribed suction amount has been satisfied at the time of suction indicates that the liquid level in the outer cylinder 511 has risen and that the space between the transmitting element and the receiving element of the ultrasonic sensor 550 has been filled with the chemical liquid. Detection is performed when the output of the receiving element of the acoustic wave sensor 550 increases and becomes constant. In addition, the injection of the specified amount at the time of injection is detected by the fact that the liquid level (interface) in the outer cylinder is lowered and the space between the transmitting element and the receiving element of the ultrasonic sensor 551 becomes air and the output of the receiving element is reduced.

  The ultrasonic sensors 550 and 551 may be provided with one transmitting element and one receiving element, respectively, or may be provided with a number of receiving elements with respect to one transmitting element. Further, although the positions of the ultrasonic sensors 550 and 551 are fixed, the ultrasonic sensors 550 and 551 may be supported by, for example, an actuator movable in the vertical direction so as to be movable in the vertical direction. Thereby, the filling amount of the chemical | medical solution with which the chemical | medical solution administration apparatus 2 is filled can be changed.

[4-2. Circuit configuration of chemical filling device]
Next, the circuit configuration and functional configuration of the chemical solution filling apparatus 5 will be described with reference to FIG.

  In the chemical solution filling device 5, each unit operates on the power source supplied from the battery 561, and the microcomputer 560 controls the whole.

  The microcomputer 560 is a computer including a CPU, a RAM, a ROM, and the like. The CPU reads and executes a basic program stored in the ROM and executes the overall control, and the CPU is stored in the ROM. Various processes are executed by reading various programs into the RAM and executing them.

  In addition to the microcomputer 560, the chemical filling device 5 includes a battery monitoring unit 562, a pump driving unit 563, a pusher driving unit 564, a pusher monitoring unit 565, a suction amount detecting unit 566, an injection amount detecting unit 567, and a clamp opening / closing unit. 568, a transmission unit 569, a reception unit 570, and a communication antenna 571 are provided.

  The battery monitoring unit 562 monitors the presence / absence, remaining amount, etc. of the battery 561 and notifies the microcomputer 560 of it. The pump drive unit 563 drives the pump 525.

  The pusher drive unit 564 drives the motor 531 of the pusher drive mechanism 530, and moves the pusher 512 in the vertical direction via the motor 531, the gear head 532, the feed screw 533, and the pusher holding unit 534.

  The pusher monitoring unit 565 determines whether or not the pusher 512 is moving in the outer cylinder 511 while the pusher driving unit 564 is moving the pusher 512 based on, for example, a current applied to the motor 531. To detect. Specifically, the pusher monitoring unit 565 determines that the gasket 512A of the pusher 512 is not moved by being caught by the inner wall of the outer cylinder 511, for example, when an overcurrent of a predetermined threshold value or more flows in the motor 531. This is notified to the microcomputer 560.

  The suction amount detection unit 566 and the injection amount detection unit 567 receive the measurement results of the ultrasonic sensors 550 and 551, and the height at which the ultrasonic sensors 550 and 551 are provided and the height of the chemical solution in the outer cylinder 511 are the same. It is detected whether it has become, and the detection result is notified to the microcomputer 560.

  The clamp opening / closing unit 568 opens and closes the clamps 540, 541, and 542 via an actuator in response to an instruction from the microcomputer 560.

  The microcomputer 560 transmits various signals to the drug solution administration device 2 and the controller 3 via the transmission unit 569 and the communication antenna 571, and signals transmitted to the drug solution administration device 2 and the controller 3 as a communication antenna 571 and a reception unit 568. Receive via.

[5. (Procedure for filling chemical with chemical filling equipment)
Next, the operation performed by the user when filling the chemical solution bag 110 of the chemical solution administration device 2 with the chemical solution filling apparatus and the procedure of the filling process performed by the microcomputer 560 will be described with reference to the flowchart shown in FIG.

  When executing the filling process, the microcomputer 560 executes the filling process by developing the filling process program stored in the ROM in the RAM and executing it.

  First, in step SP1, the user sets the syringe 510 to which the injection tube 520, the suction tube 521, and the pump tube 522 are connected to the main body 501. Specifically, the outer cylinder 511 is passed through the syringe holding part 508, the flange 511C is fitted into the syringe holding part 507, and the flange 512C of the pusher 512 is sandwiched between the pusher holding part 534. The injection needle 523 is equipped with a rubber cap, and the injection needle 523 is sealed.

  In step SP2, the user wipes and disinfects the rubber stopper 570A of the vial 570 as a chemical solution container containing the chemical solution with alcohol cotton, and punctures the suction needle portion 524 (needle 524A, needle 524B). The tip is inserted into the drug solution in vial 570. It should be noted that the needle 524B is set in advance to a length that allows the needle 524B to enter the vial 570 but not enter the drug solution.

  When the user depresses the start / stop switch 502 in this state, the microcomputer 560 executes the filling process and closes the clamp 540 provided in the injection tube 520 in step SP11. At this time, the clamps 541 and 542 provided on the suction tube 521 and the pump tube 522 remain open.

  In step SP11, the microcomputer 660 drives the pump 525 via the pump drive unit 563 to start suction.

  When the pump 525 starts suction, the internal space sandwiched between the cylinder portion 511A of the outer cylinder 511 and the gasket 512A of the pusher 512 becomes negative pressure, and the chemical solution flows into the outer cylinder 511 from the vial 570 via the suction tube 521. . At this time, since air is sucked into the vial 570 from the needle 524B, the inside of the vial 570 does not have a negative pressure, and the drug solution is sucked from the vial 570 into the internal space of the outer cylinder 511 having a negative pressure. Further, since the chemical liquid that has flowed into the internal space of the outer cylinder 511 falls downward due to gravity, it does not flow into the pump 525 via the pump tube 42.

  In step SP13, the microcomputer 560 determines whether or not the amount of drug solution to be filled in the drug solution administration device 2 has been drawn from the vial 570 into the inner space of the outer cylinder 511, and the liquid level of the drug solution stored in the inner space of the outer cylinder 511. Is detected via the ultrasonic sensor 550 and the suction amount detection unit 566. That is, the microcomputer 560 detects whether or not the chemical solution has been stored in the internal space of the outer cylinder 511 up to the height at which the ultrasonic sensor 550 is provided.

  Then, the microcomputer 560 operates the pump 525 until the chemical solution is drawn out to the height where the ultrasonic sensor 550 is provided in the internal space of the outer cylinder 511, and an amount of the chemical solution to be filled in the chemical solution administration device 2 is discharged from the vial 570. When it is pulled out to 511, the process proceeds to step SP14, where the pump 525 is stopped via the pump drive unit 563.

  In step SP15, the microcomputer 560 opens the clamp 540 of the injection tube 520 and closes the clamp 541 of the suction tube 521 and the clamp 542 of the pump tube 522.

  In step SP16, the microcomputer 560 moves the pusher 512 upward via the pusher drive unit 564 and the pusher drive mechanism 530 to forcibly suck the air in the injection tube 540, thereby injecting the injection tube 540. Remove the air present inside. When this operation is performed a plurality of times to remove air from the injection tube 540, the microcomputer 560 stops moving the pusher 512 upward, and moves the pusher 540 downward by a predetermined amount.

  The microcomputer 560 opens the clamp 542 in order to set the pressure in the syringe 510 to atmospheric pressure. By this operation, the inside of the injection tube 540 is filled with the chemical solution. Thereafter, the microcomputer 560 displays the fact on the display unit 505 and notifies the user.

  In step SP3, the user who has received the notification removes the rubber cap provided on the injection needle 523, engages the engagement portion 523A with the engagement receiving portion 101L of the drug solution administration device 2, and moves the needle 523B of the injection needle 523. Insert into the injection part 104.

  When the user presses the start / stop switch 502 again in this state, the microcomputer 560 moves the pusher 512 downward via the pusher drive unit 564 and the pusher drive mechanism 530 in step SP17, and removes the external switch. The drug solution drawn out to the cylinder 511 is injected into the drug solution administration device 2 through the injection tube 540.

  In the chemical solution administration device 2, when the chemical solution is injected from the injection unit 104, the chemical solution bag 110 does not flow only into the chemical solution bag 110, but before the chemical solution bag 110 is inflated, the nozzle 105, the filter unit 120, the channel tube 106, and the delivery unit 130. , The flow pipe 107, the valve body 108, the nozzle 302 of the puncture flow path section 30, the flowing water sensor 303, and the puncture flow path needle 304 sequentially flow into each flow path.

  At this time, the air present in the chemical solution bag 110, the nozzle 105, the filter unit 120, and the flow channel pipe 106 is discharged from the filter unit 120 to the outside. Further, the air vent filter 309A is provided at the tip of the tip portion 304B of the puncture flow path needle 304 from the air vent filter 309A. Discharged. Note that the chemical solution also flows between the puncture channel needle 304 and the sheath portion 310, but the amount thereof is very small, and the air that has existed is also discharged to the outside.

  When a chemical solution is further injected through the injection unit 104 after each channel is filled with the chemical solution, the chemical solution bag 110 is filled with the chemical solution so as to be inflated by applying pressure.

  The microcomputer 560 detects the amount of the chemical liquid injected from the outer cylinder 511 into the chemical liquid administration device 2 via the ultrasonic sensor 551 and the injection amount detection unit 567, and detects the height of the liquid level of the outer cylinder 511. When the height at which 551 is provided is filled with air, it is determined that a predetermined amount of liquid medicine has been injected into the liquid medicine administration device 2, and the movement of the pusher 512 is stopped.

  Thus, the chemical solution filling device 5 can fill the chemical solution administration device 2 with a prescribed amount of the chemical solution.

  By the way, in the conventional chemical solution administration apparatus, the user pulls out the chemical solution from the vial using a syringe and fills the chemical solution storage unit that stores the chemical solution.

  Here, in order for the user to pull out the drug solution from the vial using a syringe, a relatively strong force is required unless air is first injected with a syringe, and the device is used when the amount of drug solution in the vial is small. The handling of the needle requires safety precautions, and considering hygiene, the user is burdened with heavy skills, for example, skillful techniques are required to extract the required amount of drug solution from the vial into the syringe.

  Further, when filling the chemical solution, air may be mixed in the chemical solution storage unit. If air is mixed in the chemical solution storage unit, there may be a problem that, for example, an accurate amount of the chemical solution cannot be injected into the user, and it cannot be said that the chemical solution is properly filled. Therefore, the user needs to pay attention not to put air into the chemical solution storage unit.

  Thus, in order to properly fill the chemical solution storage part of the chemical solution administration device with the chemical solution, the user has to perform complicated operations.

  On the other hand, the chemical solution filling device 5 only allows the user to set the syringe 510, insert the suction needle portion 524 into the vial 570, and insert the injection needle 523 into the injection portion 104 only. The chemical solution bag 110 of the chemical solution administration device 2 can be filled with an accurate amount of the chemical solution.

  Therefore, the chemical solution filling device 5 can reduce the burden on the user as in the prior art and can be filled with an accurate amount of the chemical solution, thus improving usability.

[6. Other Embodiments]
[6-1. Other Embodiment 1]
In the present embodiment described above, the sheath 311 of the sheath part 310 covers most of the puncture channel needle 304 from the distal end part 304B to the front of the elastic part 304A, and the extension part 312 of the sheath part 310 is the sheath 311. The case where the puncture flow path needle 304 is covered from a position overlapping one end side on the elastic portion 304A side to just before the elastic portion 304A has been described.

  The present invention is not limited to this, and has a characteristic that when the sheath or the extended portion of the sheath portion is deformed at one end, it retains its original shape and does not return to its original shape. When 304A is extended or contracted, it is sufficient that the sheath or the extension portion is extended to maintain the shape as it is.

  For example, as shown in FIG. 24 (A) in which parts corresponding to those in FIG. 14 are denoted by the same reference numerals, as a sheath portion having a characteristic of maintaining the shape as it is once deformed and not returning to the original shape A sheath 610 covers from the distal end portion 304B of the puncture flow path needle 304 to the fixing portion 305.

  The caulking 306 holds the sheath 610 so that it does not slide relative to the puncture channel needle 304. Note that the caulking 306 is adhered to the sheath 610, and even when the caulking 306 is loosened, the caulking 306 is not separated from the sheath 610.

  When the pusher 324 pushes the caulking 306 forward until it comes into contact with the movement restricting part 307, the elastic part 304A of the puncture channel needle 304 extends, but at this time, the sheath 610 does not extend.

  When the push portion 324 enters between the overlapping members below the caulking 306 and tightens the caulking 306, the elastic portion 304A of the puncture channel needle 304 contracts. At this time, since the sheath 610 is bonded to the caulking 306, the front from the caulking 306 is not deformed, and the caulking 306 to the fixing portion 305 extend according to the contraction of the elastic portion 304A. Thereby, only the flexible sheath 610 can be continuously inserted into the body, and the puncture channel needle 304 made of metal can be returned to the outside of the body.

  As another example, as shown in FIG. 24B, the sheath portion 620 covers the portion from the distal end portion 304B of the puncture flow path needle 304 to the portion immediately before the elastic portion 304A with the sheath 621, and when the elastic portion 304A is deformed at one end, it remains as it is. Cover with an elongated portion 622 having the characteristic of maintaining the shape and not returning to the original shape.

  The extending part 622 is fixed so that one end on the fixing part 305 side is fixed to the puncture channel needle 304 and the other end covers the sheath 621. Note that the caulking 306 need not be fixed to the sheath 621.

  When the caulking 306 moves in the forward direction, the elastic portion 304A of the puncture flow path needle 304 is extended, and the extended portion 622 is extended as the elastic portion 304A is extended.

  When the push portion 324 enters between the overlapping members below the caulking 306 and tightens the caulking 306, the elastic portion 304A of the puncture channel needle 304 contracts. At this time, the sheath 620 continues to maintain the shape as it is, and the tip of the sheath 620 is maintained in a state of protruding from the bottom surface 301A.

  Thereby, when puncturing the user, the puncture channel section 30 punctures with the metal puncture channel needle 304 having a sharp tip 304B, and then continues to insert only the flexible sheath 621 into the body. The puncture channel needle 304 made of metal can be returned to the outside of the body.

[6-2. Other Embodiment 2]
Further, in the above-described embodiment, a case has been described in which the angle adjustment mechanism 340 adjusts the protrusion angle of the puncture flow path needle 304 and the sheath 311 with respect to the bottom surface 301A in order to puncture to an arbitrary depth from the epidermis. The present invention is not limited to this, and the puncture distance may be changed while the projection angle is fixed in order to puncture to an arbitrary depth from the epidermis.

  Specifically, as shown in FIGS. 25 and 26, the puncture channel unit 700 is different from the puncture channel unit 30 in that a distance adjustment mechanism 710 is provided instead of the angle adjustment mechanism 340. The distance adjusting mechanism 710 is held by the lever 713 so that the caulking guide 711 and the movement restricting portion 712 can move in the front-rear direction.

  The lever 713 is connected by a connecting portion 713C in which an operation portion 713A and a holding portion 713B extending in the front-rear direction are provided inside and outside an opening 701Q provided on the upper surface 701F of the housing portion 701, respectively, so as to penetrate the opening 701Q. The cross-section thus formed is substantially H-shaped.

  The distance adjusting mechanism 710 is provided with an O-ring 714 that prevents liquid from flowing into the housing unit 701 from the outside between the holding unit 713 </ b> B and the housing unit 701. Further, the distance adjustment mechanism 710 is provided with a spring 715 that presses the holding unit 713B against the housing unit 701 between the operation unit 713A and the housing unit 701.

  The lever 713 is provided with protrusions 713D and 713E having a substantially triangular cross section at both ends in the front-rear direction on the surface of the holding portion 713B facing the housing portion 701. Further, the housing portion 701 is provided with a plurality of grooves 701R and 701S in which the protrusions 713D and 713E engage with each other at a position facing the protrusions 713D and 713E in the front-rear direction. Note that the housing portion 701 is not provided with the opening 301J on which the knob support portion 348 of the angle adjustment mechanism 340 is placed.

  In the lever 713, the movement restriction unit 712 is fixed to a holding unit 713 </ b> B provided inside the housing unit 701. The movement restricting portion 712 is provided with a hole, and the puncture channel needle 304 and the sheath 311 are inserted through the hole.

  The movement restricting portion 712 is provided with a caulking guide 711 that guides the caulking 306 so that the caulking 306 can be moved in the front-rear direction.

  Therefore, the distance adjusting mechanism 710 moves the caulking guide 711 and the movement restricting portion 712 while the protrusions 713D and 713E are engaged with the grooves 701R and 701S by operating the operation portion 713A of the lever 713 in the front-rear direction. Let

  At this time, the distance adjustment mechanism 710 changes the distance that the caulking 306 moves to the movement limiting unit 712 when the caulking 306 is moved by the puncture mechanism 320 because the distance between the caulking 306 and the movement limiting unit 712 is changed. can do.

  As a result, the distance adjustment mechanism 710 can change the puncture distance between the puncture flow path needle 304 and the sheath 311 protruding from the bottom surface 701A of the housing portion 701. Therefore, even if the puncture angle is fixed, any distance from the body surface can be obtained. Can be punctured to depth.

  Further, both the puncture angle and the puncture distance may be changed. In this case, both the angle adjustment mechanism 340 and the distance adjustment mechanism 710 described above may be provided.

[6-3. Other Embodiment 3]
In the embodiment described above, the angle adjusting mechanism 340 rotates the holding portion 347 that holds the puncture flow path needle 304 and the sheath 311 around the center portion 342, thereby changing the puncture angles of the puncture flow path needle 304 and the sheath 311. The case where adjustment was made was described. The present invention is not limited to this.

  For example, as shown in FIG. 27, the puncture angle adjusting mechanism 800 includes a holding portion 801 made of a flexible member that holds the puncture flow path needle 304 and the sheath 311 and closes the opening 301N of the housing portion 301. It is provided so as to be rotatable about a rotation shaft 802 fixed to the portion 301.

  The holding portion 801 is a shaft portion that is applied with a constant urging force in the rearward direction by the spring 803 below the rotation shaft 802 and moves along the bending direction in accordance with the user's operation above the rotation shaft 802. 804 is contacted. One end of the shaft portion 804 is in contact with the holding portion 801 and the other end is connected to the knob portion 805.

  The puncture angle adjusting mechanism 800 moves the upper side of the rotating shaft 802 of the holding portion 801 in the rearward direction when the shaft portion 804 is moved upward along the bending direction via the knob portion 805. Accordingly, the holding portion 801 rotates around the rotation shaft 802 (clockwise in FIG. 27B).

  Thereby, the puncture angle adjustment 800 can reduce the protrusion angle of the puncture flow path needle 304 and the sheath 311 with respect to the bottom surface 301A, and thus reduce the puncture angle of the puncture flow path needle 304 and the sheath 311 with respect to the surface of the user. Can do.

  On the other hand, the puncture angle adjusting mechanism 800 is configured such that when the shaft portion 804 is moved downward along the bending direction via the knob portion 805, the shaft portion 804 is separated from the upper side of the rotation shaft 802 of the holding portion 801. Since it moves forward, the holding portion 801 is rotated around the rotation shaft 802 by the urging force of the spring 802 (counterclockwise in FIG. 27B).

  Thereby, the puncture angle adjustment 800 can increase the projection angle of the puncture flow path needle 304 and the sheath 311 with respect to the bottom surface 301A, and thus increase the puncture angle of the puncture flow path needle 304 and the sheath 311 with respect to the surface of the user. Can do.

[6-4. Other Embodiment 4]
As another example, as shown in FIGS. 28 to 30, the casing 901 of the puncture channel unit 900 is provided with an opening 901 </ b> J having a predetermined width and a predetermined length on an inclined surface 901 </ b> H inclined from the upper surface 901 </ b> F to the front surface 901 </ b> G. It is done. A plurality of substantially triangular grooves 901R are provided at predetermined intervals on one side surface of the opening 901J. In addition, L-shaped ribs are provided on both sides of the back surface of the 901H inclined surface in the longitudinal direction of the 901J opening.

  The angle adjustment mechanism 910 includes a knob 911, a knob support portion 912, a leaf spring 913, a tip holding portion 914, a leaf spring 915, an engagement portion 916, a step portion 917, and a stopper 918.

  The knob support portion 912, the leaf spring 913, the tip holding portion 914, the leaf spring 915, and the engagement portion 916 are continuously connected along the inside of the inclined surface 901H, the front surface 901G, the bottom surface 901A, and the back surface 901V of the housing portion 901. Is done.

  The knob 911 includes an opening 901J provided on the inclined surface 901H of the housing 901 and an L-shaped rib installed on the back side of the opening 901J and a knob support portion 912 that is held movably between the back surface of the inclined surface 901H. It is fixed to the knob support portion 912 with screws 911A so as to be sandwiched.

  The knob support portion 912 is a substantially triangular protrusion made of a plate-shaped spring material in which a protruding portion 912A protruding from the knob 911 is located in the opening 901J and fitted into the protruding portion 912A. A rectangular spring 912B, which is a rectangular spring having a, is arranged so as to fit in the groove 901R.

  The knob support portion 912 is provided with a waterproof packing 912C on the edge of the upper surface, and prevents liquid from entering the housing portion 901 from between the inclined surface 901H.

  The tip support portion 914 is made of, for example, an elastomer, has flexibility, and is disposed so as to close the opening 901 </ b> N and be in contact with the outer periphery of the sheath 311.

  The tip support portion 914 is fitted to an L-shaped rib provided inside the bottom surface 901A, and both sides are shifted in the front-rear direction along the inside of the front surface 901G and the back surface 901V of the 901. Due to the flexibility, even if the distal end portion 304B of the puncture flow path needle 304 and the distal end of the sheath 311 are moved to the angle adjusting mechanism 910, they can follow it and continue to block the opening 901N. Accordingly, liquid can be prevented from entering the housing portion 301.

  The tip support portion 914 has a semi-cylindrical tilt stopper 914 </ b> B protruding in the vertical direction in front of the cover portion 914 </ b> A covering the puncture flow path needle 304 and the sheath 311. Thereby, even if the distal end support portion 913 moves backward, the puncture channel needle 304 and the sheath 311 can ensure 90 degrees.

  The engaging portion 916 has a claw portion 916A whose end opposite to the end to which the leaf spring 915 is connected protrudes to the step portion 917 side. Yes.

  The step portion 917 is formed in a substantially triangular prism shape having an inclined surface inclined at a predetermined inclination angle φ (52 degrees in this embodiment) from the front to the rear in the foremost direction inside the bottom surface 901B. The In the step portion 917, a plurality of steps 917A are provided on the inclined surface at the same intervals as the intervals of the grooves 901R, and the claw portions 916A of the engaging portions 916 engage with the steps 917A.

  As shown in FIG. 30A, the angle adjusting mechanism 910 configured as described above has a knob support portion 912 so that the protruding angle of the puncture channel needle 304 and the sheath 310 is the smallest 20 degrees as shown in FIG. The protrusion 912B is engaged with the uppermost groove 90R of the housing portion 901, and the claw portion 916A of the engagement portion 916 is disposed at a position where it engages with the lowermost step 917A of the step portion 917.

  Then, the angle adjustment mechanism 910 engages the projection 912B of the knob support portion 912 with the groove 90R of the housing portion 901 while being shifted one by one in accordance with the operation of moving the knob 911 downward by the user. The claw portion 916A of the joining portion 916 engages while shifting the step 917A of the step portion 917 step by step. Thereby, the angle adjustment mechanism 910 gradually increases the protruding angles of the puncture flow path needle 304 and the sheath 310.

  In the angle adjusting mechanism 910, when the knob 911 is moved to the lowest position according to the user's operation, the protrusion of the rectangular spring 912B of the knob support portion 912 is engaged with the lowermost groove 90R of the housing portion 901. The claw portion 916A of the engaging portion 916 engages with the uppermost step of the step 917A of the step portion 917. At this time, in the angle adjusting mechanism 910, the stopper 918 is located inside the upper surface 901F of the housing 901, and the protruding angle of the puncture flow path needle 304 and the sheath 310 is set to 90 degrees.

  By the way, in the angle adjustment mechanism 910, the protrusion angle of the puncture channel needle 304 and the sheath 310 is changed from 20 ° to 90 ° when the knob 911 is positioned at the uppermost stage and when the knob 911 is positioned at the lowermost stage. The distance between the tip of the puncture flow path needle 304 and the sheath 310 and the lower surface (puncture hole) of the holding portion 914 changes accordingly.

  Therefore, in the angle adjustment mechanism 910, a fixed puncture depth is required unless the moving distance of the tip of the puncture flow path needle 304 and the sheath 310 is corrected for the change distance between the puncture flow path needle 304 and the sheath 310 and the lower surface of the holding portion 914. Cannot be maintained.

  In view of this, the angle adjustment mechanism 910 adjusts the position of the stopper 918, but the amount of puncture holding unit 914 to move back and forth, the tip of puncture channel needle 304 and sheath 310, and the lower surface of the holding unit 914 (puncture hole). Since the movement distance is different from the above, the movement amount of the stopper 918 is corrected by the inclination angle of the step portion 917 as shown in the equation (1).

Movement amount of step unit 917 = Amount of front / rear movement of puncture holding unit 914 × COSφ (1)
Note that φ is the inclination angle of the step portion 917.

  In this manner, the angle adjustment mechanism 910 can adjust the puncture angles of the puncture flow path needle 304 and the sheath 311 with respect to the surface of the user.

[6-5. Other Embodiment 5]
Further, in the above-described embodiment, the case where the puncture release mechanism 330 is configured by the limiting portion 331, the spring 332, and the actuator 333 has been described. However, the present invention is not limited thereto, and control by the microcomputer 220 is performed. Any device that can receive and open the support plate 323 may be used.

  For example, as shown in FIG. 31, the puncture release mechanism 1000 includes a limiting portion 331, a spring 332, a stopper 1001, and a nichrome wire 1002. The limiting portion 331 and the spring 332 are the same as the puncture release mechanism 330.

  The stopper 1001 abuts one surface of the flange portion 1001A formed in a substantially U shape so that the rear side of the rotation shaft 331A of the limiting portion 331 is fitted to the upper surface of the limiting portion 331 on the rear side of the rotation shaft 331A.

  The flange portion 1001A is connected to the elongated melting portion 1001B, and is fixed to the housing portion 301 through the melting portion 1001B.

  In the stopper 1001, a nichrome wire 1002 through which a current flows under the control of the microcomputer 220 is wound around the melting portion 1001B a plurality of times.

  When the microcomputer 220 punctures the user with the puncture channel needle 304 and the sheath 311, an electric current is passed through the nichrome wire 1002 to melt the melting portion 1001 </ b> B with the heat. At this time, in the puncture release mechanism 1000, the control unit 331 is released from the stopper 1001, and the limiting unit 331 is rotated counterclockwise about the rotation shaft 331 A by the force of returning to the natural length of the spring 332, and is released from the support plate 323. Leave. As a result, the puncture mechanism 320 punctures the user with the puncture channel needle 304 and the sheath 311.

[6-6. Other Embodiment 6]
In the above-described embodiment, the case where one convex portion 342A is provided in the central portion 342 and the plurality of concave portions 342A is provided in the support portion 341 has been described, but the present invention is not limited to this, and the center A plurality of convex portions 342A may be provided on the portion 342, and one concave portion 342A may be provided on the support portion 341. In addition, one or a plurality of concave portions may be provided in the central portion 342, and a plurality of or one convex portion may be provided in the support portion 341.

[6-7. Other Embodiment 7]
In the above-described embodiment, the case where the side surface connecting portions 511D and 511E are provided at the same height has been described. However, the present invention is not limited to this, and the side surface connecting portion 511E is positioned higher than the side surface connecting portion 511D. You may make it provide in.

  Thereby, when the pump 525 sucks out the chemical solution from the vial 570, it is possible to prevent the chemical solution from flowing into the pump 525.

[6-8. Other Embodiment 8]
In the embodiment described above, the case where the transmission unit 221, the reception unit 222, and the flow detection control unit 224 have a hardware configuration different from that of the microcomputer 220 has been described, but the present invention is not limited to this, and the microcomputer 220 may have a software configuration that functions as a transmission unit, a reception unit, and a flow detection control unit, or a part of the transmission unit, the reception unit, and the flow detection control unit may have a hardware configuration and the others may have a software configuration. Good.

  In the above-described embodiment, the case where the battery monitoring unit 303, the transmission unit 307, and the reception unit 308 have a hardware configuration different from that of the microcomputer 301 has been described. However, the present invention is not limited to this, and the microcomputer A software configuration 301 may function as a battery monitoring unit, a transmission unit, and a reception unit, or a part of the battery monitoring unit, the transmission unit, and the reception unit may have a hardware configuration, and the others may have a software configuration.

  In the above-described embodiment, the battery monitoring unit 562, the pump driving unit 563, the pusher driving unit 564, the pusher monitoring unit 565, the suction amount detecting unit 566, the injection amount detecting unit 567, and the clamp opening / closing unit 568 are included in the microcomputer. Although the case where the hardware configuration is different from that of 560 has been described, the present invention is not limited to this, and the microcomputer 301 has a battery monitoring unit, a pump driving unit, a pusher driving unit, a pusher monitoring unit, and a suction amount detection control. May be a software configuration that functions as an injection unit, an injection amount detection control unit, and a clamp opening / closing unit, a battery monitoring unit, a pump drive unit, a pusher drive unit, a pusher monitoring unit, a suction amount detection control unit, an injection amount detection A part of the control unit and the clamp opening / closing unit may have a hardware configuration and the others may have a software configuration.

  Further, in the above-described embodiment, the case where the clamps 540, 541, and 542 are opened and closed by the control of the microcomputer 560 in the chemical solution filling device 5 is described, but the present invention is not limited to this, and is opened and closed by the user. A clamp may be used.

  The present invention can be applied to the medical field, for example.

  DESCRIPTION OF SYMBOLS 1 ... Chemical solution administration system, 2 ... Chemical solution administration apparatus, 3 ... Controller, 4 ... Charger, 5 ... Chemical solution filling apparatus, 10 ... Chemical solution storage and delivery part, 20 ... Drive control part, 30 ... Puncture flow path portion, 101 ... lower housing portion, 102 ... upper housing portion, 110 ... chemical solution bag, 120 ... filter portion, 130 ... delivery portion, 136 ... drive magnet, 137 ... position Magnet for detection, 140... Compression section, 201... Upper casing section, 202... Lower casing section, 206... Charging site, 207. , 211... Magnetic sensor, 212... Connector, 304... Puncture flow path needle, 310 .. sheath portion, 311 .. sheath, 312 .. extension portion, 320. 340 ... Angle adjustment mechanism, 510 ... Siri Di-, 525 ...... pump, 530 ...... pusher drive mechanism.

Claims (3)

A portable drug administration device held in a living body,
A chemical storage section for storing the chemical,
A compression part that compresses the liquid medicine pack;
A delivery section for delivering the chemical stored in the chemical pack to the outside,
The chemical storage part is a sheet-like member,
A bottom surface portion and a top surface portion, which have a predetermined area and are the bottom surface and the top surface of the chemical solution storage unit formed by folding;
A side surface portion formed between the bottom surface portion and the top surface portion and connected to the respective edges and having an oddly folded shape at least three times in a direction overlapping the bottom surface portion and the top surface portion. A chemical solution administration device. The medicinal solution storage unit is a rectangular sheet-shaped member,
The center of the member is a bottom surface portion, a part of the end side adjacent to the bottom surface portion along the longitudinal direction of the member is a side surface portion, and further from the side surface portion, the end side along the longitudinal direction of the member The medicinal-solution administration device according to claim 1, wherein the top surface portion is formed by connecting each other, the side surface portion is folded back, and the edge in the width direction of the member in the bottom surface portion and the top surface portion is connected. The medical solution administration device according to claim 1, further comprising: a filter unit that is provided between the medical solution storage unit and the delivery unit and discharges gas to the outside without allowing the liquid to pass therethrough.

Images